Jinzhou Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jinzhou Huang has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Zhenkun Lou
Department of Oncology, Mayo Clinic, Rochester, USA
7 shared publications - Jake A. Kloeber
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
6 shared publications Kuntian Luo
Department of Oncology, Mayo Clinic, Rochester, USA
5 shared publicationsPing Yin
Department of Oncology, Mayo Clinic, Rochester, USA
4 shared publicationsFei Zhao
Department of Oncology, Mayo Clinic, Rochester, USA
3 shared publications- Hongyang Huang
Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
3 shared publications
Latest Publications
- 8 January 2026
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 33 (2) , 293-303
Redox-driven ADAR1 activation promotes Okazaki fragment maturation and DNA replication integrity
Okazaki fragment maturation requires efficient removal of RNA primers to form a continuous lagging strand, yet how mismatched primers introduced by error-prone primase are corrected remains unresolved. Here, we show that physiological levels of reactive oxygen species (ROS) initiate a redox-dependent mechanism that drives ADAR1-mediated adenosine-to-inosine (A-to-I) editing. Oxidation triggers ADAR1 dimerization at replication forks, enhancing RNA editing of mismatched primers—particularly those caused by ATP misincorporation on d(T+C)-rich centromeric DNA. This A-to-I editing step facilitates more efficient RNA primer degradation by RNase H2, thereby ensuring proper Okazaki fragment maturation. Disruption of ADAR1 oxidation results in increased unligated Okazaki fragments, single-stranded gaps and double-strand breaks, most prominently at centromeres. These findings reveal a role for ROS in safeguarding lagging-strand synthesis by coupling ADAR1 oxidation-induced A-to-I RNA editing to replication fork stability.
- 8 January 2026
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 33 (2) , 293-303
Redox-driven ADAR1 activation promotes Okazaki fragment maturation and DNA replication integrity
Okazaki fragment maturation requires efficient removal of RNA primers to form a continuous lagging strand, yet how mismatched primers introduced by error-prone primase are corrected remains unresolved. Here, we show that physiological levels of reactive oxygen species (ROS) initiate a redox-dependent mechanism that drives ADAR1-mediated adenosine-to-inosine (A-to-I) editing. Oxidation triggers ADAR1 dimerization at replication forks, enhancing RNA editing of mismatched primers—particularly those caused by ATP misincorporation on d(T+C)-rich centromeric DNA. This A-to-I editing step facilitates more efficient RNA primer degradation by RNase H2, thereby ensuring proper Okazaki fragment maturation. Disruption of ADAR1 oxidation results in increased unligated Okazaki fragments, single-stranded gaps and double-strand breaks, most prominently at centromeres. These findings reveal a role for ROS in safeguarding lagging-strand synthesis by coupling ADAR1 oxidation-induced A-to-I RNA editing to replication fork stability.
- Open Access
- 8 October 2025
- Published by Springer Nature in Nature
- Vol. 648 (8092) , 210-219
KCTD10 is a sensor for co-directional transcription–replication conflicts
During DNA replication, the replisome must remove barriers and roadblocks including the transcription machinery1,2. Transcription–replication conflicts (TRCs) occur when there are collisions between the replisome and transcription machinery, and are increasingly recognized as an important source of mammalian genome instability3. How cells facilitate replisome bypass at sites of TRCs is incompletely understood. Here we show that the CUL3–KCTD10 E3 ligase senses TRCs and promotes remodelling of the RNA polymerase complex to allow replisome bypass. We found that the substrate adaptor KCTD10 interacts with the replisome and the transcription machinery and regulates both in unstressed conditions. These bivalent interactions allow KCTD10 to detect co-directional TRCs and facilitate higher-order assembly of KCTD10 complexes that recruit CUL3 to induce the ubiquitination and removal of the RNA polymerase factor TCEA2. In the absence of KCTD10, there is increased retention of TCEA2 and the RNA polymerase complex, causing an accumulation of TRCs and increased DNA damage. Our results demonstrate how replication can proceed through transcriptionally active regions, utilizing a unique bridging function of the CUL3–KCTD10 complex. These findings provide a framework for how the coordination between transcription and replication may contribute to the maintenance of genome stability.
- 8 October 2025
- Published by Springer Nature in Nature
- Vol. 648 (8092) , 210-219
Open AccessKCTD10 is a sensor for co-directional transcription–replication conflicts
During DNA replication, the replisome must remove barriers and roadblocks including the transcription machinery1,2. Transcription–replication conflicts (TRCs) occur when there are collisions between the replisome and transcription machinery, and are increasingly recognized as an important source of mammalian genome instability3. How cells facilitate replisome bypass at sites of TRCs is incompletely understood. Here we show that the CUL3–KCTD10 E3 ligase senses TRCs and promotes remodelling of the RNA polymerase complex to allow replisome bypass. We found that the substrate adaptor KCTD10 interacts with the replisome and the transcription machinery and regulates both in unstressed conditions. These bivalent interactions allow KCTD10 to detect co-directional TRCs and facilitate higher-order assembly of KCTD10 complexes that recruit CUL3 to induce the ubiquitination and removal of the RNA polymerase factor TCEA2. In the absence of KCTD10, there is increased retention of TCEA2 and the RNA polymerase complex, causing an accumulation of TRCs and increased DNA damage. Our results demonstrate how replication can proceed through transcriptionally active regions, utilizing a unique bridging function of the CUL3–KCTD10 complex. These findings provide a framework for how the coordination between transcription and replication may contribute to the maintenance of genome stability.
- 25 January 2023
- Published by Elsevier in Molecular Cell
- Vol. 83 (4) , 539-555.e7
SUMOylation of HNRNPA2B1 modulates RPA dynamics during unperturbed replication and genotoxic stress responses
- 25 January 2023
- Published by Elsevier in Molecular Cell
- Vol. 83 (4) , 539-555.e7
SUMOylation of HNRNPA2B1 modulates RPA dynamics during unperturbed replication and genotoxic stress responses
- 11 July 2022
- Published by Springer Nature in Oncogene
- Vol. 41 (33) , 4018-4027
The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1
Heme oxygenase-1 (HO-1) is an inducible heme degradation enzyme that plays a cytoprotective role against various oxidative and inflammatory stresses. However, it has also been shown to exert an important role in cancer progression through a variety of mechanisms. Although transcription factors such as Nrf2 are involved in HO-1 regulation, the posttranslational modifications of HO-1 after oxidative insults and the underlying mechanisms remain unexplored. Here, we screened and identified that the deubiquitinase USP7 plays a key role in the control of redox homeostasis through promoting HO-1 deubiquitination and stabilization in hepatocytes. We used low-dose arsenic as a stress model which does not affect the transcriptional level of HO-1, and found that the interaction between USP7 and HO-1 is increased after arsenic exposure, leading to enhanced HO-1 expression and attenuated oxidative damages. Furthermore, HO-1 protein is ubiquitinated at K243 and subjected to degradation under resting conditions; whereas when after arsenic exposure, USP7 itself can be ubiquitinated at K476, thereafter promoting the binding between USP7 and HO-1, finally leading to enhanced HO-1 deubiquitination and protein accumulation. Moreover, depletion of USP7 and HO-1 inhibit liver tumor growth in vivo, and USP7 positively correlates with HO-1 protein level in clinical human hepatocellular carcinoma (HCC) specimens. In summary, our findings reveal a critical role of USP7 as a HO-1 deubiquitinating enzyme in the regulation of oxidative stresses, and suggest that USP7 inhibitor might be a potential therapeutic agent for treating HO-1 overexpressed liver cancers.
- 11 July 2022
- Published by Springer Nature in Oncogene
- Vol. 41 (33) , 4018-4027
The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1
Heme oxygenase-1 (HO-1) is an inducible heme degradation enzyme that plays a cytoprotective role against various oxidative and inflammatory stresses. However, it has also been shown to exert an important role in cancer progression through a variety of mechanisms. Although transcription factors such as Nrf2 are involved in HO-1 regulation, the posttranslational modifications of HO-1 after oxidative insults and the underlying mechanisms remain unexplored. Here, we screened and identified that the deubiquitinase USP7 plays a key role in the control of redox homeostasis through promoting HO-1 deubiquitination and stabilization in hepatocytes. We used low-dose arsenic as a stress model which does not affect the transcriptional level of HO-1, and found that the interaction between USP7 and HO-1 is increased after arsenic exposure, leading to enhanced HO-1 expression and attenuated oxidative damages. Furthermore, HO-1 protein is ubiquitinated at K243 and subjected to degradation under resting conditions; whereas when after arsenic exposure, USP7 itself can be ubiquitinated at K476, thereafter promoting the binding between USP7 and HO-1, finally leading to enhanced HO-1 deubiquitination and protein accumulation. Moreover, depletion of USP7 and HO-1 inhibit liver tumor growth in vivo, and USP7 positively correlates with HO-1 protein level in clinical human hepatocellular carcinoma (HCC) specimens. In summary, our findings reveal a critical role of USP7 as a HO-1 deubiquitinating enzyme in the regulation of oxidative stresses, and suggest that USP7 inhibitor might be a potential therapeutic agent for treating HO-1 overexpressed liver cancers.
- Open Access
- 6 January 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (2) , 101563
m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis
- 6 January 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (2) , 101563
Open Accessm6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis
- Open Access
- 17 November 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination
BRCA1-BARD1 heterodimers act in multiple steps during homologous recombination (HR) to ensure the prompt repair of DNA double strand breaks. Dysfunction of the BRCA1 pathway enhances the therapeutic efficiency of poly-(ADP-ribose) polymerase inhibitors (PARPi) in cancers, but the molecular mechanisms underlying this sensitization to PARPi are not fully understood. Here, we show that cancer cell sensitivity to PARPi is promoted by the ring between ring fingers (RBR) protein RNF19A. We demonstrate that RNF19A suppresses HR by ubiquitinating BARD1, which leads to dissociation of BRCA1-BARD1 complex and exposure of a nuclear export sequence in BARD1 that is otherwise masked by BRCA1, resulting in the export of BARD1 to the cytoplasm. We provide evidence that high RNF19A expression in breast cancer compromises HR and increases sensitivity to PARPi. We propose that RNF19A modulates the cancer cell response to PARPi by negatively regulating the BRCA1-BARD1 complex and inhibiting HR-mediated DNA repair.
- 17 November 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
Open AccessRNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination
BRCA1-BARD1 heterodimers act in multiple steps during homologous recombination (HR) to ensure the prompt repair of DNA double strand breaks. Dysfunction of the BRCA1 pathway enhances the therapeutic efficiency of poly-(ADP-ribose) polymerase inhibitors (PARPi) in cancers, but the molecular mechanisms underlying this sensitization to PARPi are not fully understood. Here, we show that cancer cell sensitivity to PARPi is promoted by the ring between ring fingers (RBR) protein RNF19A. We demonstrate that RNF19A suppresses HR by ubiquitinating BARD1, which leads to dissociation of BRCA1-BARD1 complex and exposure of a nuclear export sequence in BARD1 that is otherwise masked by BRCA1, resulting in the export of BARD1 to the cytoplasm. We provide evidence that high RNF19A expression in breast cancer compromises HR and increases sensitivity to PARPi. We propose that RNF19A modulates the cancer cell response to PARPi by negatively regulating the BRCA1-BARD1 complex and inhibiting HR-mediated DNA repair.
- 9 July 2020
- Published by Elsevier in Molecular Cell
- Vol. 79 (5) , 824-835.e5
Tandem Deubiquitination and Acetylation of SPRTN Promotes DNA-Protein Crosslink Repair and Protects against Aging
- 9 July 2020
- Published by Elsevier in Molecular Cell
- Vol. 79 (5) , 824-835.e5
Tandem Deubiquitination and Acetylation of SPRTN Promotes DNA-Protein Crosslink Repair and Protects against Aging
- Top Cited Papers
- 1 October 2017
- Published by Elsevier in Molecular Cell
- Vol. 68 (1) , 171-184.e6
A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth
- 1 October 2017
- Published by Elsevier in Molecular Cell
- Vol. 68 (1) , 171-184.e6
Top Cited PapersA Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth
- 11 March 2016
- Published by Wiley in The Journal of Pathology
- Vol. 239 (2) , 186-196
Down‐regulation of TRPS1 stimulates epithelial–mesenchymal transition and metastasis through repression of FOXA1
The tricho–rhino–phalangeal syndrome 1 gene (TRPS1), which was initially found to be associated with tricho–rhino–phalangeal syndrome, is critical for the development and differentiation of bone, hair follicles and kidney. However, its role in cancer progression is largely unknown. In this study, we demonstrated that down‐regulation of TRPS1 correlated with distant metastasis, tumour recurrence and poor survival rate in cancer patients. TRPS1 was frequently down‐regulated in high‐metastatic cancer cell lines from the breast, colon and nasopharynx. Silencing of TRPS1 stimulated epithelial–mesenchymal transition (EMT), migration and invasion in vitro and metastasis in vivo, while TRPS1 over‐expression exhibited the opposite effects. Using quantitative proteomics, FOXA1, a negative regulator of epithelial–mesenchymal transition (EMT), was shown to be down‐regulated by TRPS1 knockdown. Ectopic expression of FOXA1 blocked the enhancement of EMT, migration and invasion induced by TRPS1 silencing. Mechanistically, TRPS1, acting as a transcription activator, directly induced FOXA1 transcription by binding to the FOXA1 promoter. We further showed that down‐regulation of TRPS1 was induced by miR‐373 binding to the 3′ UTR of TRPS1. Over‐expression of TRPS1, but not TRPS1 3′ UTR, blocked the enhancement of migration and invasion induced by miR‐373. Taken together, we consider that down‐regulation of TRPS1 by miR‐373, acting as a transcriptional activator, promotes EMT and metastasis by repressing FOXA1 transcription, expanding upon its previously reported role as a transcription repressor. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
- 11 March 2016
- Published by Wiley in The Journal of Pathology
- Vol. 239 (2) , 186-196
Down‐regulation of TRPS1 stimulates epithelial–mesenchymal transition and metastasis through repression of FOXA1
The tricho–rhino–phalangeal syndrome 1 gene (TRPS1), which was initially found to be associated with tricho–rhino–phalangeal syndrome, is critical for the development and differentiation of bone, hair follicles and kidney. However, its role in cancer progression is largely unknown. In this study, we demonstrated that down‐regulation of TRPS1 correlated with distant metastasis, tumour recurrence and poor survival rate in cancer patients. TRPS1 was frequently down‐regulated in high‐metastatic cancer cell lines from the breast, colon and nasopharynx. Silencing of TRPS1 stimulated epithelial–mesenchymal transition (EMT), migration and invasion in vitro and metastasis in vivo, while TRPS1 over‐expression exhibited the opposite effects. Using quantitative proteomics, FOXA1, a negative regulator of epithelial–mesenchymal transition (EMT), was shown to be down‐regulated by TRPS1 knockdown. Ectopic expression of FOXA1 blocked the enhancement of EMT, migration and invasion induced by TRPS1 silencing. Mechanistically, TRPS1, acting as a transcription activator, directly induced FOXA1 transcription by binding to the FOXA1 promoter. We further showed that down‐regulation of TRPS1 was induced by miR‐373 binding to the 3′ UTR of TRPS1. Over‐expression of TRPS1, but not TRPS1 3′ UTR, blocked the enhancement of migration and invasion induced by miR‐373. Taken together, we consider that down‐regulation of TRPS1 by miR‐373, acting as a transcriptional activator, promotes EMT and metastasis by repressing FOXA1 transcription, expanding upon its previously reported role as a transcription repressor. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.